Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 425

Related Citations for PubMed (Select 18222670)

1.

Lobeline, a piperidine alkaloid from Lobelia can reverse P-gp dependent multidrug resistance in tumor cells.

Ma Y, Wink M.

Phytomedicine. 2008 Sep;15(9):754-8. doi: 10.1016/j.phymed.2007.11.028. Epub 2008 Jan 28.

PMID:
18222670
3.
4.

Quinoline derivative KB3-1 potentiates paclitaxel induced cytotoxicity and cycle arrest via multidrug resistance reversal in MES-SA/DX5 cancer cells.

Koo JS, Choi WC, Rhee YH, Lee HJ, Lee EO, Ahn KS, Bae HS, Ahn KS, Kang JM, Choi SU, Kim MO, Lu J, Kim SH.

Life Sci. 2008 Nov 21;83(21-22):700-8. doi: 10.1016/j.lfs.2008.09.009. Epub 2008 Sep 24.

PMID:
18845169
6.
8.

Reversal of p-glycoprotein-mediated multidrug resistance by macrocyclic bisbibenzyl derivatives in adriamycin-resistant human myelogenous leukemia (K562/A02) cells.

Li X, Sun B, Zhu CJ, Yuan HQ, Shi YQ, Gao J, Li SJ, Lou HX.

Toxicol In Vitro. 2009 Feb;23(1):29-36. doi: 10.1016/j.tiv.2008.09.015. Epub 2008 Oct 1.

PMID:
18938236
9.
10.

Substituted tetrahydroisoquinoline compound B3 inhibited P-glycoprotein-mediated multidrug resistance in-vitro and in-vivo.

Fang W, Li Y, Cai Y, Kang K, Yan F, Liu G, Huang W.

J Pharm Pharmacol. 2007 Dec;59(12):1649-55.

PMID:
18053326
11.

Role of the MDR-1-encoded multiple drug resistance phenotype in prostate cancer cell lines.

Theyer G, Schirmböck M, Thalhammer T, Sherwood ER, Baumgartner G, Hamilton G.

J Urol. 1993 Nov;150(5 Pt 1):1544-7.

PMID:
8105110
12.

Reversal effect of substituted 1,3-dimethyl-1H-quinoxalin-2-ones on multidrug resistance in adriamycin-resistant K562/A02 cells.

Sun LR, Li X, Cheng YN, Yuan HY, Chen MH, Tang W, Ward SG, Qu XJ.

Biomed Pharmacother. 2009 Mar;63(3):202-8. doi: 10.1016/j.biopha.2008.07.090. Epub 2008 Aug 28.

PMID:
18818047
13.

Mitochondrial localization and activity of P-glycoprotein in doxorubicin-resistant K562 cells.

Munteanu E, Verdier M, Grandjean-Forestier F, Stenger C, Jayat-Vignoles C, Huet S, Robert J, Ratinaud MH.

Biochem Pharmacol. 2006 Apr 14;71(8):1162-74. Epub 2006 Feb 24.

PMID:
16499877
14.

Reversal of P-glycoprotein mediated multidrug resistance by a newly synthesized 1,4-benzothiazipine derivative, JTV-519.

Che XF, Nakajima Y, Sumizawa T, Ikeda R, Ren XQ, Zheng CL, Mukai M, Furukawa T, Haraguchi M, Gao H, Sugimoto Y, Akiyama S.

Cancer Lett. 2002 Dec 10;187(1-2):111-9.

PMID:
12359358
15.

Development of rational in vitro models for drug resistance in breast cancer and modulation of MDR by selected compounds.

Kars MD, Iseri OD, Gündüz U, Ural AU, Arpaci F, Molnár J.

Anticancer Res. 2006 Nov-Dec;26(6B):4559-68.

16.

Inhibitory effect of steroidal alkaloids on drug transport and multidrug resistance in human cancer cells.

Lavie Y, Harel-Orbital T, Gaffield W, Liscovitch M.

Anticancer Res. 2001 Mar-Apr;21(2A):1189-94.

PMID:
11396162
17.

Proteasome inhibitors can alter the signaling pathways and attenuate the P-glycoprotein-mediated multidrug resistance.

Fujita T, Washio K, Takabatake D, Takahashi H, Yoshitomi S, Tsukuda K, Ishibe Y, Ogasawara Y, Doihara H, Shimizu N.

Int J Cancer. 2005 Nov 20;117(4):670-82.

PMID:
15945097
18.

S9788 modulation of P-glycoprotein- and Multidrug-related protein-mediated multidrug resistance by Servier 9788 in doxorubicin-resistant MCF7 cells.

Bichat F, Solis-Recendez G, Poullain MG, Poupon MF, Khayat D, Bastian G.

Biochem Pharmacol. 1998 Aug 15;56(4):497-502.

PMID:
9763226
19.

Inhibition of P-glycoprotein activity by limonin and other secondary metabolites from Citrus species in human colon and leukaemia cell lines.

El-Readi MZ, Hamdan D, Farrag N, El-Shazly A, Wink M.

Eur J Pharmacol. 2010 Jan 25;626(2-3):139-45. doi: 10.1016/j.ejphar.2009.09.040. Epub 2009 Sep 24.

PMID:
19782062
20.
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk